Published : Apr-2020
No. of Pages : 46
1.1 List of Tables
1.2 List of Figures
2 Age-Related Macular Degeneration: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Total Prevalent Cases of AMD, Early AMD, Late AMD, Late Dry AMD, and Late Wet AMD
3.4.4 Total Prevalent Cases of AMD by Laterality
3.4.5 Total Prevalent Cases of Total Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD
3.4.6 Diagnosed Prevalent Cases of AMD, Early AMD, Late AMD, Late Dry AMD, and Late Wet AMD
3.5 Epidemiological Forecast for AMD, 2018-2028
3.5.1 Total Prevalent Cases of AMD
3.5.2 Age-Specific Total Prevalent Cases of AMD
3.5.3 Sex-Specific Total Prevalent Cases of AMD
3.5.4 Total Prevalent Cases of AMD by Laterality
3.5.5 Total Prevalent Cases of Early AMD
3.5.6 Total Prevalent Cases of Late AMD
3.5.7 Total Prevalent Cases of Late Dry AMD
3.5.8 Total Prevalent Cases of Late Wet AMD
3.5.9 Total Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD
3.5.10 Diagnosed Prevalent Cases of AMD
3.5.11 Age-Specific Diagnosed Prevalent Cases of AMD
3.5.12 Sex-Specific Diagnosed Prevalent Cases of AMD
3.5.13 Diagnosed Prevalent Cases of Early AMD
3.5.14 Diagnosed Prevalent Cases of Late AMD
3.5.15 Diagnosed Prevalent Cases of Late Dry AMD
3.5.16 Diagnosed Prevalent Cases of Late Wet AMD
3.5.17 Diagnosed Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 Primary Research - Prescriber Survey
4.3 About the Authors
4.3.1 Epidemiologist
4.3.2 Reviewers
4.3.3 Global Director of Therapy Analysis and Epidemiology
4.3.4 Global Head and EVP of Healthcare Operations and Strategy
4.4 About GlobalData
4.5 Contact Us
4.6 Disclaimer
List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Risk Factors and Comorbidities for AMD
Table 3: High-Prescribing Physicians (KOL and non-KOLs) Surveyed, By Country
List of Figures
Figure 1: 9MM, Total Prevalent Cases of AMD, Both Sexes, Ages ?50 Years, 2018 and 2028
Figure 2: 9MM, Diagnosed Prevalent Cases of AMD, Both Sexes, Ages ?50 Years, 2018 and 2028
Figure 3: 9MM, Total Prevalence of AMD, Men and Women, Ages ?50 Years, %, 2018
Figure 4: 9MM, Diagnosed Prevalence of AMD, Men and Women, Ages ?50 Years, 2018
Figure 5: 9MM, Sources Used and Not Used to Forecast the Total Prevalent Cases of AMD, Early AMD, Late AMD, Late Dry AMD, and Late Wet AMD
Figure 6: 9MM, Sources Used to Forecast the Total Prevalent Cases of AMD by Laterality
Figure 7: 9MM, Sources Used to Forecast the Total Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD and Diagnosed Prevalent Cases of AMD, Early AMD, Late AMD, Late Dry AMD, and Late Wet AMD
Figure 8: 9MM, Total Prevalent Cases of AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 9: 9MM, Total Prevalent Cases of AMDby Age, Both Sexes, N, 2018
Figure 10: 9MM, Total Prevalent Cases of AMD, by Sex, Ages ?50 Years, N, 2018
Figure 11: 9MM, Total Prevalent Cases of AMD by Laterality, Ages ?50 Years, Both Sexes, N, 2018
Figure 12: 9MM, Total Prevalent Cases of Early AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 13: 9MM, Total Prevalent Cases of Late AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 14: 9MM, Total Prevalent Cases of Late Dry AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 15: 9MM, Total Prevalent Cases of Late Wet AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 16: 9MM, Total Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 17: 9MM, Diagnosed Prevalent Cases of AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 18: 9MM, Diagnosed Prevalent Cases of AMD by Age, Both Sexes, N, 2018
Figure 19: 9MM, Diagnosed Prevalent Cases of AMD, by Sex, Ages ?50 Years, N, 2018
Figure 20: 9MM, Diagnosed Prevalent Cases of Early AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 21: 9MM, Diagnosed Prevalent Cases of Late AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 22: 9MM, Diagnosed Prevalent Cases of Late Dry AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 23: 9MM, Diagnosed Prevalent Cases of Late Wet AMD, Both Sexes, Ages ?50 Years, N, 2018
Figure 24: 9MM, Diagnosed Prevalent Cases of Geographic Atrophy Secondary to Late Dry AMD, Both Sexes, Ages ?50 Years, N, 2018
